KEITH BARNES: Open Payments
NPI 1972695518 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$426 in 14 payments from 9 companies in 2025. Trend: 2023 $18 · 2024 $58 · 2025 $426
Food & beverage: $426
| Company | Payments | Amount |
|---|---|---|
| HARMONY BIOSCIENCES LLC | 6 | $202 |
| Lilly USA, LLC | 1 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $33 |
| Genmab U.S., Inc. | 1 | $30 |
| Iovance Biotherapeutics, Inc. | 1 | $21 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $17 |
| Exelixis Inc. | 1 | $16 |
Products named: WAKIX, NINLARO, Tivdak, Amtagvi, ENJAYMO, LIBTAYO, IBRANCE, CABOMETYX.
Industry payments across TX — which companies pay providers there.
